Boric Acid
Natural health product licensed in Canada
- Licence holder
- Goldensea Wellness & Beauty Ltd.
- NPN or DIN-HM
- 80124815
- Status
- Active licence
- Licence date
- 7 June 2023
- Revision date
- Not provided
- Form
- Suppositoire
- Route of administration
- Vaginale
- Application type
- Générale (non traditionelle)
Oral dose analysis does not apply without an established exclusively oral route.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source |
|---|---|
| Acide borique (H3BO3) Source : Acide borique Potency : 17 % Boron | 600 mg |
Non-medicinal ingredients
Eau purifiée, Gélatine
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Femmes | minimum: 18 years | 1 suppositoire | 1 Tous les jours |
Uses authorised in Canada
Text supplied in English because no French text is available.
May help to reduce the incidence of recurrent Vulvovaginal Candidiasis. Helps with symptoms of recurrent Yeast Vaginitis and Vulvovaginal Candidiasis. Helps to reduce the overgrowth of recurrent or resistant vaginal yeast.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
No French warning text available in the imported data.
Source
Official Health Canada record, licence 80124815
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
The evidence date of this ingredient list is unknown.
Has the product changed? Photograph the packaging.